Triple
T9812304
| Position | Surface form | Disambiguated ID | Type / Status |
|---|---|---|---|
| Subject | aflibercept |
E238303
|
entity |
| Predicate | targets |
P860
|
FINISHED |
| Object | VEGF-A |
E823216
|
NE FINISHED |
How this triple was built (2 steps)
Every LLM step that produced this triple, in pipeline order — named-entity classification, the disambiguation choices (the exact options shown, with the pick highlighted), and the generated description. The batch + timestamp of each is in the Provenance table below.
NER
Named-entity recognition
gpt-5-mini
Instruction
Given a phrase, classify it is english named entity (e.g., persons, organizations, works of art) in Latin script, or not (e.g., literals, dates, URLs, verbose phrases). For disambiguation, the statement where the phrase occurs as object is also given. Please return a JSON object with `phrase` (string, the phrase being analyzed) and `is_ne` (boolean, indicating whether the phrase is a Named Entity).
Input
Phrase: VEGF-A | Statement: [aflibercept, targets, VEGF-A]
NED1
Entity disambiguation (via context triple)
gpt-5-mini-2025-08-07
Target entity: VEGF-A Context triple: [aflibercept, targets, VEGF-A]
-
A.
vascular endothelial growth factor A
chosen
Vascular endothelial growth factor A (VEGF-A) is a key signaling protein that promotes the growth of new blood vessels and increases vascular permeability, playing a central role in angiogenesis and various diseases such as cancer and eye disorders.
-
B.
VEGF-B
VEGF-B is a member of the vascular endothelial growth factor family involved in blood vessel biology and tissue survival, particularly in the heart and nervous system.
-
C.
platelet-derived growth factor
Platelet-derived growth factor is a key signaling protein that regulates cell growth, proliferation, and angiogenesis, and plays important roles in wound healing and various pathological conditions such as cancer and fibrosis.
-
D.
aflibercept
Aflibercept is an anti-VEGF biologic drug used primarily to treat neovascular (wet) age-related macular degeneration and other retinal vascular diseases.
-
E.
EGF
EGF is the ICAO airline designator used to identify American Eagle Airlines in aviation operations and communications.
- F. None of above.
- G. Unsure - the case is ambiguous/there is not enough information to decide.
Provenance (3 batches)
The batch behind each pipeline step, in order, with when it ran. Timestamps are batch-level — stages were processed in waves, so the object chain (NER → NED1 → NEDg → NED2) reads in order, but predicate / elicitation batches can sit in a different wave.
| Step | Stage | Batch ID | Status | When |
|---|---|---|---|---|
| creating | Elicitation | batch_69ca84defac48190abc1148804f184c1 |
completed | March 30, 2026, 2:12 p.m. |
| NER | Named-entity recognition | batch_69cdb222ba788190a9085272a3de7852 |
completed | April 2, 2026, 12:02 a.m. |
| NED1 | Entity disambiguation (via context triple) | batch_69d1d5b264c88190bf16c8c32c360878 |
completed | April 5, 2026, 3:23 a.m. |
Created at: March 30, 2026, 8:30 p.m.